PACIFIC BIOSCIENCES OF CALIF (PACB) Stock News
NASDAQ:PACB - Nasdaq - US69404D1081 - Common Stock - Currency: USD
PACB Latest News, Press Releases and Analysis
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...
PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025
MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss...
PacBio Announces Appointment of Chris Smith to Board of Directors
PacBio to leverage Chris' extensive expertise in diagnostics and laboratory testing markets, as Board Member David Meline steps down....
PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics
New sequencing approach resolves the genetic complexity of a rare Mendelian condition...
PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider
MENLO PARK, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...
PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics
MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of highly accurate long-read sequencing solutions,...
PacBio Announces Preliminary Fourth Quarter and Full Year Revenue
Commenced shipment of the Vega™ benchtop system ahead of schedule, bringing HiFi sequencing to more customers Launched SPRQ chemistry, enabling the...
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing
MENLO PARK, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus...
PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets
Berry Genomics will leverage PacBio Vega System to develop long-read sequencing-based solutions for patients in China and other countries...
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
With Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
With Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025.
PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference
MENLO PARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...
Deciphering Disruption: Inside Cathie Wood's Latest Plays
Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The rock star money manager is starting to roll with the rallying market.
PacBio to Present at Upcoming Investor Conferences
MENLO PARK, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...
PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028
MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...
PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop
Priced at just $169,000 Vega is designed to make highly accurate long-read sequencing accessible to any laboratory...
Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep
/PRNewswire/ -- Volta Labs™, a genomics applications company, announced today that it has joined the PacBio Compatible program, further expanding the...
PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500
New long-read sequencing chemistry reduces DNA input requirements four-fold, enables a 33% increase in data output per SMRT Cell, improves methylation...
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program
MENLO PARK, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate genomic sequencing...
PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing
Groundbreaking collaboration to unlock the full potential of PacBio’s Onso technology, accelerating breakthroughs in cancer genomics across Asia...
PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024
MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss...
PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore
The new lab will leverage PacBio’s HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in...
PacBio Grants Equity Incentive Award to New Employee
MENLO PARK, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms,...
PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific
Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy Loss...
Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital
Highly Accurate Long-Read Sequencing Data from Revio will Support Germany’s National Genome Initiative and Provide Data to the International Male...